Hiroaki Shima

Human endoplasmic reticulum oxidoreductin 1‐α is a novel predictor for poor prognosis of breast cancer

Goro Kutomi, Yasuaki Tamura, Tsutomu Tanaka et al. · Cancer Science · 2013 · 90 citations · Full text

Breast Oncology, Pathology, Cancer Biology +16

Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2<scp>B</scp>‐derived peptide vaccination for advanced pancreatic cancer patients

Hidekazu Kameshima, Tetsuhiro Tsuruma, Goro Kutomi et al. · Cancer Science · 2012 · 77 citations · Full text

Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma

Hiroaki Shima, Giichiro Tsurita, Satoshi Wada et al. · Cancer Science · 2019 · 54 citations · Full text

Peptide Vaccination, Immunodeficiencies, Vaccination Therapy +22

Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study

Hitoshi Zembutsu, Seigo Nakamura, Sadako Akashi‐Tanaka et al. · Clinical Cancer Research · 2016 · 36 citations

Erector spinae plane block versus retrolaminar block for postoperative analgesia after breast surgery: a randomized controlled trial

Sayaka Sotome, Atsushi Sawada, Asaka Wada et al. · Journal of Anesthesia · 2020 · 33 citations

Health Sciences, Pain Medicine, Postoperative Pain Management +9